Table III.
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Characteristics | No. of patients | OS, 1-year rate (%) | P-value | P-value |
Age, years | ||||
<60 | 48 | 42 | ||
≥60 | 50 | 28 | 0.23 | n.s. |
Sex | ||||
Male | 65 | 33 | ||
Female | 33 | 33 | 0.66 | n.s. |
Performance status | ||||
0–1 | 56 | 46 | ||
2–3 | 42 | 19 | 0.003 | 0.03 |
RT technique | ||||
IMRT/SBRT | 83 | 41 | ||
3D-CRT | 15 | 0 | 0.08 | n.s. |
BED10 | ||||
<60 Gy10 | 39 | 26 | ||
≥60 Gy10 | 59 | 41 | 0.29 | n.s. |
Interval between two RT | ||||
<1-year | 44 | 14 | ||
≥1-year | 54 | 50 | <0.0001 | <0.0001 |
RT, radiation therapy; IMRT, intensity-modulated radiotherapy; SBRT, stereotactic body radiotherapy; 3D-CRT, three-dimensional conformal radiotherapy; BED10, biological effective dose in Gy for α/β value of 10 Gy; OS, overall survival; n.s., not statistically significant.